These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 7662237
1. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients. Lebel M, Kingma I, Grose JH, Langlois S. Am J Hypertens; 1995 Jun; 8(6):545-51. PubMed ID: 7662237 [Abstract] [Full Text] [Related]
2. Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO). Roger SD, Baker LR, Raine AE. Clin Nephrol; 1993 Feb; 39(2):103-10. PubMed ID: 8448912 [Abstract] [Full Text] [Related]
3. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration]. Zehnder C, Blumberg A. Schweiz Med Wochenschr; 1990 Feb 17; 120(7):217-20. PubMed ID: 2309110 [Abstract] [Full Text] [Related]
4. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients. Frenken LA, Verberckmoes R, Michielsen P, Koene RA. Nephrol Dial Transplant; 1989 Feb 17; 4(9):782-6. PubMed ID: 2516609 [Abstract] [Full Text] [Related]
5. [Treatment of anemia in patients with chronic kidney insufficiency in hemodialysis with erythropoietin]. Prata MM, de Sousa FT, Barbas JV, da Costa AM, Vinhas J, Moreira P, Abrantes C, Lopes MC. Acta Med Port; 1990 Feb 17; 3(3):149-53. PubMed ID: 2220424 [Abstract] [Full Text] [Related]
6. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results. Phair JP, Abels RI, McNeill MV, Sullivan DJ. Arch Intern Med; 1993 Dec 13; 153(23):2669-75. PubMed ID: 8250662 [Abstract] [Full Text] [Related]
9. [Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration]. Stutz B, Rhyner K, Vögtli J, Binswanger U. Schweiz Med Wochenschr; 1987 Sep 19; 117(38):1397-402. PubMed ID: 3672079 [Abstract] [Full Text] [Related]
10. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis]. Graf H, Mayer G, Cada EM, Thum J, Stummvoll HK. Wien Klin Wochenschr; 1987 Dec 18; 99(24):855-9. PubMed ID: 3439185 [Abstract] [Full Text] [Related]
11. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment]. Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL. Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug 18; 25(8):710-4. PubMed ID: 15555399 [Abstract] [Full Text] [Related]
17. [The treatment of anemia in patients on hemodialysis with recombinant human erythropoietin]. Borrego FJ, Miguel JL, Zamorano A, Muñoz J, Bajo A, López-Revuelta K, Sánchez Sicilia L. Med Clin (Barc); 1991 Nov 23; 97(18):687-92. PubMed ID: 1770818 [Abstract] [Full Text] [Related]